Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 351

2.

Expression of p53, p21/WAF/CIP, Bcl-2, Bax, Bcl-x, and Bak in radiation-induced apoptosis in testicular germ cell tumor lines.

Burger H, Nooter K, Boersma AW, Kortland CJ, van den Berg AP, Stoter G.

Int J Radiat Oncol Biol Phys. 1998 May 1;41(2):415-24.

PMID:
9607360
3.

Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in testicular germ cell tumour cell lines.

Burger H, Nooter K, Boersma AW, Kortland CJ, Stoter G.

Br J Cancer. 1998 May;77(10):1562-7.

5.

5-Fluorouracil induces apoptosis in human colon cancer cell lines with modulation of Bcl-2 family proteins.

Nita ME, Nagawa H, Tominaga O, Tsuno N, Fujii S, Sasaki S, Fu CG, Takenoue T, Tsuruo T, Muto T.

Br J Cancer. 1998 Oct;78(8):986-92.

6.

Relationship between topoisomerase II level and chemosensitivity in human tumor cell lines.

Fry AM, Chresta CM, Davies SM, Walker MC, Harris AL, Hartley JA, Masters JR, Hickson ID.

Cancer Res. 1991 Dec 15;51(24):6592-5.

7.

P53, bcl-2 and bax immunoreactivity as predictors of response and outcome after chemotherapy for metastatic germ cell testicular tumours.

Baltaci S, Orhan D, Türkölmez K, Yesilli C, Bedük Y, Tulunay O.

BJU Int. 2001 May;87(7):661-6.

8.

Influence of p53 and bcl-2 on chemosensitivity in benign and malignant prostatic cell lines.

Serafin AM, Bohm L.

Urol Oncol. 2005 Mar-Apr;23(2):123-9.

PMID:
15869997
9.

Apoptosis and cancer chemotherapy.

Chresta CM, Arriola EL, Hickman JA.

Behring Inst Mitt. 1996 Oct;(97):232-40. Review.

PMID:
8950479
10.

Role of p53 in G2/M cell cycle arrest and apoptosis in response to gamma-irradiation in ovarian carcinoma cell lines.

Concin N, Stimpfl M, Zeillinger C, Wolff U, Hefler L, Sedlak J, Leodolter S, Zeillinger R.

Int J Oncol. 2003 Jan;22(1):51-7.

PMID:
12469184
12.

Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status.

Mirjolet JF, Barberi-Heyob M, Didelot C, Peyrat JP, Abecassis J, Millon R, Merlin JL.

Br J Cancer. 2000 Nov;83(10):1380-6.

13.
16.

Complex response of breast epithelial cell lines to topoisomerase inhibitors.

Davis PL, Shaiu WL, Scott GL, Iglehart JD, Hsieh TS, Marks JR.

Anticancer Res. 1998 Jul-Aug;18(4C):2919-32.

PMID:
9713486
17.

Normal p53 status and function despite the development of drug resistance in human breast cancer cells.

Wosikowski K, Regis JT, Robey RW, Alvarez M, Buters JT, Gudas JM, Bates SE.

Cell Growth Differ. 1995 Nov;6(11):1395-403.

18.

Human T-cell leukemia virus I tax protein sensitizes p53-mutant cells to DNA damage.

Mihaylova VT, Green AM, Khurgel M, Semmes OJ, Kupfer GM.

Cancer Res. 2008 Jun 15;68(12):4843-52. doi: 10.1158/0008-5472.CAN-07-5070.

19.

p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents.

Fan S, el-Deiry WS, Bae I, Freeman J, Jondle D, Bhatia K, Fornace AJ Jr, Magrath I, Kohn KW, O'Connor PM.

Cancer Res. 1994 Nov 15;54(22):5824-30.

20.

Supplemental Content

Support Center